MedTrace Logo

Melatonin and Glucose Tolerance Among Individuals With a Variant of the MTNR1B Gene

NCT01705639 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2017-01-04

No results posted yet for this study

Summary

The effect of 3 months of melatonin 4mg treatment on glucose tolerance in different variants of the melatonin receptor 1B gene will be evaluated. The following will be done at 0 and 3 months:

* OGTT
* questionnaires about sleep and activity
* Actigraph
* Anthropometry
* Blood pressure

Conditions

Interventions

DRUG

Melatonin

All subjects receive the same dose of melatonin

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Folkhalsan Research Center

    collaborator UNKNOWN

  • University of Helsinki

    lead OTHER

Principal Investigators

  • Leif Groop, Prof. · University of Lund, University of Helsinki

  • Tiinamaija Tuomi, Docent · Helsinki University Central Hospital

  • Bo Isomaa, Docent · Folkhalsan

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01705639 on ClinicalTrials.gov